Meirong Chen

Meirong Chen

Auto-generated profile, based on publicly available information

Meirong Chen

GeneMind Biosciences Co., Ltd. , Shenzhen 518000, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
PDF file
FCFang Chen
Fang Chen
BLBin Liu
Bin Liu
MCMeirong Chen
Meirong Chen
ZJZefei Jiang
Zefei Jiang
ZZZhiliang Zhou
Zhiliang Zhou
QYQin Yan
Qin Yan
DNA sequencers have become increasingly important research and diagnostic tools over the past 20 years. In this study, we developed a single-molecule desktop sequencer, GenoCare 1600 (GenoCare), which utilizes amplification-free library preparation and two-color sequencing-by-synthesis chemistry, making it more user-friendly compared with previous single-molecule sequencing platforms for clinical use. Using the GenoCare platform, we sequenced an Escherichia coli standard sample and achieved a consensus accuracy exceeding 99.99%. We also evaluated the sequencing performance of this platform in microbial mixtures and coronavirus disease 2019 (COVID-19) samples from throat swabs. Our findings indicate that the GenoCare platform allows for microbial quantitation, sensitive identification of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and accurate detection of virus mutations, as confirmed by Sanger sequencing, demonstrating its remarkable potential in clinical application.